Deep vein thrombosis as a public health priority: wHO's agenda for Africa 2030

Deep vein thrombosis (DVT) is a serious vascular condition characterized by the formation of blood clots in deep veins, predominantly in the lower limbs. Despite its significant morbidity and mortality worldwide, DVT remains an under-recognized public health issue in Africa, where limited awareness, diagnostic challenges, and resource constraints contribute to suboptimal prevention and management. The rising burden of risk factors such as obesity, HIV infection, infectious diseases, and sedentary lifestyles highlights the urgent need to prioritize DVT within the continent's healthcare agenda. The World Health Organization (WHO) has identified the control of DVT as a critical component of its 2030 health strategy for Africa, emphasizing integration into non-communicable disease and cardiovascular health programs. Strategic priorities include enhancing epidemiological surveillance, increasing healthcare provider and community awareness, strengthening diagnostic capacity, and implementing evidence-based thromboprophylaxis guidelines. However, challenges such as inadequate infrastructure, limited access to anticoagulant therapies, and sociocultural barriers hinder effective DVT control across many African settings. Addressing these challenges requires a coordinated, multisectoral approach that incorporates capacity building, resource mobilization, and policy reforms aligned with WHO's vision. By elevating DVT as a public health priority, African nations can improve early detection, prevention, and management of venous thromboembolism, ultimately reducing preventable complications and improving vascular health outcomes across the continent.